Skip to main content

Advertisement

Log in

Two strikes against mycophenolate mofetil therapy for myasthenia gravis

  • Clinical Trials Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Phillips LH: The epidemiology of myasthenia gravis. Semin Neurol 2004, 24:17–20.

    Article  PubMed  Google Scholar 

  2. Hauser RA, Malek AR, Rosen R: Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil. Neurology 1998, 51:912–913.

    PubMed  CAS  Google Scholar 

  3. Ciafaloni E, Massey JM, Tucker-Lipscomb B, Sanders DB: Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology 2001, 56:97–99.

    PubMed  CAS  Google Scholar 

  4. Chaudhry V, Cornblath DR, Griffin JW, et al.: Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 2001, 56:94–96.

    PubMed  CAS  Google Scholar 

  5. Meriggioli MN, Rowin J, Richman JG, Leurgans S: Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Ann N Y Acad Sci 2003, 998:494–499.

    Article  PubMed  CAS  Google Scholar 

  6. Meriggioli MN, Ciafaloni E, Al-Hayk KA, et al.: Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability. Neurology 2003, 61:1438–1440.

    PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirano, M. Two strikes against mycophenolate mofetil therapy for myasthenia gravis. Curr Neurol Neurosci Rep 9, 57–58 (2009). https://doi.org/10.1007/s11910-009-0009-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-009-0009-6

Keywords

Navigation